Teva Pharmaceutical Industries Ltd.'s first-quarter earnings fell 27 percent, as generic competition, a weaker Japanese yen and other factors dragged down revenue for one of the world's largest generic drugmakers. The Israeli company said Thursday U.S. ...
See all stories on this topic »
↧
Teva Pharmaceutical 1Q profit sinks 27 percent Alerts - "Teva Pharmaceutical Industries Ltd."
↧